TELA Bio (TELA) Other Non-Current Liabilities (2018 - 2026)
TELA Bio (TELA) posted quarterly Other Non-Current Liabilities of $1.4 million for Q1 2026, up 5.77% year-over-year from $1.3 million in Q1 2025, and down 5.69% quarter-over-quarter from $1.5 million in Q4 2025.
TELA Bio (TELA) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
TELA Bio's Other Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- In Q1 2026, Other Non-Current Liabilities rose 5.77% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 5.77% YoY), while the FY2025 annual figure was $1.5 million, up 6.26% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $1.4 million, down from $1.5 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $1.7 million in Q4 2023, with the low at $1.1 million in Q3 2023.
- The 5-year median for Other Non-Current Liabilities is $1.4 million (2022), against an average of $1.4 million.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Liabilities surged 16925.0% in 2022, then decreased 18.78% in 2025.
- TELA Bio's Other Non-Current Liabilities stood at $1.2 million in 2022, then soared by 36.88% to $1.7 million in 2023, then retreated by 17.51% to $1.4 million in 2024, then increased by 6.26% to $1.5 million in 2025, then retreated by 5.69% to $1.4 million in 2026.
- Business Quant data shows TELA's Other Non-Current Liabilities at $1.4 million in Q1 2026, $1.5 million in Q4 2025, and $1.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | TELA Bio | 36.34 Mn | 5.92 Mn | 13.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.31 Mn |
| Mar 31, 2026 | 1.39 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 1.56 Mn |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.61 Mn |
| Dec 31, 2023 | 1.69 Mn |
| Sep 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 1.23 Mn |
| Sep 30, 2022 | 1.28 Mn |
| Jun 30, 2022 | 1.33 Mn |
| Mar 31, 2022 | 1.36 Mn |
| Dec 31, 2021 | 380,000.00 |
| Sep 30, 2021 | 388,000.00 |